In addition, along with increased VE-cadherin, we also detected reductions in vimentin and α-actin, which suggests that the change from an endothelial into a mesenchymal phenotype observed in PAH [51] was dampened after MSC administration. The gene discussed is VIM; the disease is pulmonary arterial hypertension.